Form 483

Nitto Avecia Pharma Services, Inc. Form 483, 2017-11-02

FDA issued a Form 483 to Nitto Avecia Pharma Services, Inc. on 2017-11-02 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

Nitto Avecia Pharma Services, Inc. · Irvine, United States · Issued November 2, 2017

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Nov 2017
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Linda Thai, Walden H Lee, Jennifer M Gogley, Jolanna A Norton

2 Nov 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Linda Thai, Walden H Lee, Jennifer M Gogley, Jolanna A Norton

2 Nov 2017
21 CFR 211.165(e)

Test methods

Cited by Linda Thai, Walden H Lee, Jennifer M Gogley, Jolanna A Norton

2 Nov 2017
21 CFR 211.166(a)(4)

Testing in same container - closure system

Cited by Linda Thai, Walden H Lee, Jennifer M Gogley, Jolanna A Norton

2 Nov 2017
21 CFR 211.188(b)(7)

Actual yield, % of theoretical yield

Cited by Linda Thai, Walden H Lee, Jennifer M Gogley, Jolanna A Norton

Inspected site

NANitto Avecia Pharma Services, Inc.Irvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(7)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere